5 results
8-K
EX-2.1
KIN
Kindred Biosciences Inc
1 Jul 21
Entry into a Material Definitive Agreement
9:05am
DFAN14A
EX-2.1
ELAN
Elanco Animal Health Incorporated
1 Jul 21
Additional proxy materials by non-management
9:02am
DEFA14A
EX-2.1
KIN
Kindred Biosciences Inc
16 Jun 21
Additional proxy soliciting materials
6:44am
8-K
EX-2.1
KIN
Kindred Biosciences Inc
16 Jun 21
Form of Support Agreement
6:42am
8-K
EX-2.1
KIN
Kindred Biosciences Inc
16 Mar 20
Kindred Biosciences Announces MiratazĀ® (mirtazapine transdermal ointment) Transaction and Reports Fourth Quarter and Full Year 2019 Financial Results
4:08pm
- Prev
- 1
- Next